Skip to main content

Table 1 Demographic and imaging characteristics of patients in groups A and B

From: Transarterial chemoembolisation in patients with hepatocellular carcinoma: low-dose doxorubicin reduces post-embolisation syndrome without affecting survival—prospective interventional study

 

Group A (n = 15)

Group B (n = 13)

Statistical test

p value

Age (years)

 Mean ± standard deviation

60.8 ± 6.4

56.6 ± 6.8

t = 1.674

0.106

 Median (minimum–maximum)

60 (53–74)

55 (44–66)

Gender

 Male

12 (80%)

12 (92.3%)

χ2 = 0.862

0.600 (FE)

 Female

3 (20%)

1 (7.7%)

Number of TACE procedures

 1

1 (6.7%)

0 (0%)

χ2 = 1.202

0.842 (MC)

 2

8 (53.3%)

6 (46.2%)

 3

6 (40%)

7 (53.8%)

Number of lesions per patient

 1

6 (40%)

4 (30.8%)

χ2 = 0.776

0.871 (MC)

 2

8 (53.3%)

7 (53.8%)

 3

1 (6.7%)

2 (15.4%)

Pattern of masses in CT/MRI

 Irregular

8 (53.3%)

5 (38.5%)

χ2 = 0.619

0.431

 Well-defined

7 (46.7%)

8 (61.5%)

Size of masses in cm

 Mean ± standard deviation

7.4 ± 2.2

6.7 ± 2.1

t = 0.854

0.401

 Median (minimum–maximum)

7 (4–11)

7 (3–11)

  1. FE Fisher exact, MC Monte Carlo, t Student t test, p p value for comparing between the studied groups